Atrial fibrillation
Newly diagnosed heart failure patient with an EF of 20%. Atrial fibrillation events recorded by LifeVest altered the course of treatment for the patient.
Learn how ECGs captured by the LifeVest® wearable cardioverter defibrillator (WCD) enables physicians to modify the treatment path for their patients.
Atrial fibrillation
Newly diagnosed heart failure patient with an EF of 20%. Atrial fibrillation events recorded by LifeVest altered the course of treatment for the patient.
Sinus tachycardia
STEMI patient post-PCI with an EF of 29%. Sinus tachycardia events recorded by LifeVest altered the course of treatment for the patient.
Syncope
STEMI patient with an EF of 30%. Data recorded by LifeVest revealed recurring bradycardia events that required pacemaker implantation.
Bradycardia
NSTEMI patient with an EF of 30%. Bradycardia events recorded by LifeVest revealed significant underlying cardiovascular disease.
Sustained VT
Dilated cardiomyopathy patient with an EF of ≤ 35%. A ventricular tachycardia event recorded by LifeVest altered the course of treatment for the patient.
Trends
Non-ischemic cardiomyopathy patient with an EF of 20%. Data collected from LifeVest altered the course of treatment for the patient.
Developed with machine learning, LifeVest ECG Classifier filters out noise and identifies arrhythmias that may require intervention — from ablation to ICD implant.
Next Generation garment:
AI-enhanced algorithm:
Proven outcomes:
Most comprehensive WCD coverage:
ECG Classifier:
Patient app: